Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TILE Pilot Study
NCT04794569Phase 4Terminated
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Nov 2021
- Primary completion
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tinzaparin in deep vein thrombosis (DVT) and post-thrombotic syndrome (PTS) (2 arms), sponsored by Sunnybrook Health Sciences Centre. Primary endpoints: Post-Thrombotic Syndrome at 6 months and Main feasibility at 3 months. Started Nov 2021; status: terminated.
02
Drugs
tinzaparin
03
Conditions
deep vein thrombosis (DVT)post-thrombotic syndrome (PTS)
Beyond the preview
Go deeper on NCT04794569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04794569.